Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Huashan Hospital
Huashan Hospital
M.D. Anderson Cancer Center
Institut Pasteur du Cambodge
Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati
Stanford University
Baylor College of Medicine
Baylor College of Medicine
Columbia University
University Hospital Freiburg
University of Pittsburgh
Pediatric Transplantation & Cellular Therapy Consortium
University of Oxford
Columbia University
Beijing Neurosurgical Institute
Henry Ford Health System
Duke University
Northwestern University
University of Birmingham
Medical College of Wisconsin
Seoul National University Bundang Hospital
Shenzhen Geno-Immune Medical Institute
Seoul National University Hospital
Henry Ford Health System
Syneos Health
Institut Català d'Oncologia
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Sun Yat-sen University